Opportunity overview
NHS Greater Glasgow and Clyde intends to purchase Ru-106 Eye Applicators from Eckert & Ziegler for specialist ocular brachytherapy treatments delivered within NHS Scotland. The purchase includes the supply of radioactive Ru-106 ophthalmic applicators and associated technical support services as required by the clinical service.
Awarded to
Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.
Eckert & Ziegler BEBIG GmbH
- Contract value
- £200k
- Awarded
- Not supplied
- Contract signed
- 3 Aug 2026
- Award ID
- 085901-2026-MM/EZ/2026-1
- Status
- active
- Location
- Berlin, DE300, 13125, Germany
Classification
- CPV33151000 — Radiotherapy devices and supplies
Lots
- Ru-106 eye applicators are ophthalmic brachytherapy plaques used primarily for treating uveal melanoma, retinoblastoma, and other ocular tumors. They consist of a thin film of Ru-106 beta-emitting isotope, encapsulated in pure silver sheets, with a total thickness of only 1 mm, making them easy to handle and position on the eye surface. The beta radiation has a limited range, allowing high doses to tumors up to 5 mm in thickness while sparing sensitive structures like the optic disc and fovea. Additional information: Approximately six (6) Ru-106 Eye Applicators required to be purchased and returned per year, this contract will cover a 36 month periodValue not stated